These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. [Therapy of hypertension in the elderly: Fosinopril in Old Patients Study (FOPS)]. Koch J; Greminger P; Simeon-Dubach D Praxis (Bern 1994); 1997 Nov; 86(45):1779-84. PubMed ID: 9446181 [TBL] [Abstract][Full Text] [Related]
7. Pemphigus foliaceus associated with cilazapril. Buzón E; Pérez-Bernal AM; de la Peña F; Ríos JJ; Camacho F Acta Derm Venereol; 1998 May; 78(3):227. PubMed ID: 9602237 [No Abstract] [Full Text] [Related]
8. Treatment of senile hypertension: the Fosinopril in Old Patients Study (FOPS). Vetter W Am J Hypertens; 1997 Oct; 10(10 Pt 2):255S-261S. PubMed ID: 9366282 [TBL] [Abstract][Full Text] [Related]
9. CCBs vs ACE inhibitors in patients with diabetes. Zamorski MA J Fam Pract; 1998 Jul; 47(1):12-3. PubMed ID: 9673598 [No Abstract] [Full Text] [Related]
10. Transient myocardial dysfunction associated with angiotensin-converting enzyme inhibitor-induced angioedema: recognition by serial echocardiographic studies. Blomberg PJ; Surks HK; Long A; Rebeiz E; Mochizuki Y; Pandian N J Am Soc Echocardiogr; 1999 Dec; 12(12):1107-9. PubMed ID: 10588789 [TBL] [Abstract][Full Text] [Related]
11. Metabolic effects of long-term angiotensin-converting enzyme inhibition with fosinopril in patients with essential hypertension: relationship to angiotensin-converting enzyme inhibition. Reneland R; Andersson PE; Haenni A; Lithell H Eur J Clin Pharmacol; 1994; 46(5):431-6. PubMed ID: 7957538 [TBL] [Abstract][Full Text] [Related]
12. Angiotensin-converting-enzyme inhibitors and angiotensin II receptor blockers induced pemphigus: A case series and literature review. Palleria C; Bennardo L; Dastoli S; Iannone LF; Silvestri M; Manti A; Nisticò SP; Russo E; De Sarro G Dermatol Ther; 2019 Jan; 32(1):e12748. PubMed ID: 30238580 [TBL] [Abstract][Full Text] [Related]
13. Fosinopril: a reappraisal of its pharmacology and therapeutic efficacy in essential hypertension. Wagstaff AJ; Davis R; McTavish D Drugs; 1996 May; 51(5):777-91. PubMed ID: 8861547 [TBL] [Abstract][Full Text] [Related]
14. ACE inhibitors: review of four new agents. Binder SB Am Fam Physician; 1993 Oct; 48(5):851-7. PubMed ID: 8213415 [TBL] [Abstract][Full Text] [Related]
15. [Effectiveness and tolerance of fosinopril in the treatment of arterial hypertension of mild and medium severity]. Rosolová H; Cech J; Sefrna F Vnitr Lek; 2001 Dec; 47(12):834-9. PubMed ID: 11826546 [TBL] [Abstract][Full Text] [Related]
17. The efficacy and tolerability of fosinopril in Chinese type 2 diabetic patients with moderate renal insufficiency. Tong PC; Ko GT; Chan WB; Ma RC; So WY; Lo MK; Lee KF; Ozaki R; Chow CC; Cockram CS; Chan JC Diabetes Obes Metab; 2006 May; 8(3):342-7. PubMed ID: 16634995 [TBL] [Abstract][Full Text] [Related]
18. The effects of ACE inhibitor therapy on left ventricular myocardial mass and diastolic filling in previously untreated hypertensive patients: a cine MRI study. Hoffmann U; Globits S; Stefenelli T; Loewe C; Kostner K; Frank H J Magn Reson Imaging; 2001 Jul; 14(1):16-22. PubMed ID: 11436209 [TBL] [Abstract][Full Text] [Related]
19. Successful treatment of fosinopril-induced severe cholestatic jaundice with plasma exchange. Chou JW; Yu CJ; Chuang PH; Lai HC; Hsu CH; Cheng KS; Peng CY; Chiang IP Ann Pharmacother; 2008 Dec; 42(12):1887-92. PubMed ID: 19017832 [TBL] [Abstract][Full Text] [Related]
20. Therapeutic conversion from fosinopril to benazepril at a Veterans Affairs medical center. Gates R; Cookson T; Ito M; Marcus D; Gifford A; Le TN; Nguyen CN Am J Health Syst Pharm; 2006 Jun; 63(11):1066-8. PubMed ID: 16709894 [No Abstract] [Full Text] [Related] [Next] [New Search]